US-based medical device company Phillips-Medisize has agreed to acquire contract engineering and manufacturing services provider Injectronics.

The terms of the transaction have not been disclosed.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Following the acquisition, Phillips-Medisize will establish two manufacturing locations in the Northeast of the US as the hubs of biopharmaceutical and medical device innovation.

"This transaction is consistent with our strategic focus to further broaden our reach into the Northeastern US, and will enable us to better serve our biopharmaceutical and medical device customers."

Phillips-Medisize will retain the current management team to continue overlooking Injectronics’ Clinton and Westborough locations in Massachusetts, which will continue to serve existing customers.

Phillips-Medisize president CEO and chairman Matt Jennings said: "Injectronics has a very strong track record of delivering excellent quality service to their diagnostics and medical device customers, and adding their expertise will further solidify our position as an industry leader.

See Also:

"This transaction is consistent with our strategic focus to further broaden our reach into the Northeastern US, and will enable us to better serve our biopharmaceutical and medical device customers.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"Our two companies have similar cultures, and we admire Injectronics’ commitment to investing in their people, processes, and purpose-built facilities."

Phillips-Medisize offers design and manufacturing services to the drug delivery and combination products commercial market.

Upon completion of the transaction, the company will house more than 3,900 people in 17 production locations across the US, Europe, Mexico and China.